Here’s what you should know:
1. Allergan CEO Brent Saunders said in a release, “We continue to believe that Allergan stock is substantially undervalued, and the share price today presents a unique investment opportunity for the Company. Our financial strength and cash flow, strong portfolio of products, and diversified pipeline allow us to balance return of capital to shareholders through a flexible share repurchase program.”
2. Allergan’s stock opened at $211.62 today, hitting $215.38 at 9:30 a.m. EST.
3. In a separate release, Allergan CFO Tessa Hilado announced her intentions to retire. The company started a search for her replacement. Ms. Hilado will remain with Allergan until a successor is named.
More articles on gastroenterology:
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.